Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo-controlled trial

被引:27
|
作者
Lange, DS
Richards, HM
Guarnieri, J
Humeniuk, JM
Savin, RC
Reyes, BA
Hickman, J
Pariser, DM
Pariser, RJ
Sherertz, EF
Grossman, RM
Gisoldi, EM
Klausner, MA
机构
[1] Janssen Pharmaceut, Dept Med Affairs, Titusville, NJ 08560 USA
[2] Upstate Clin Res, Greer, SC USA
[3] Savin Dermatol Ctr, New Haven, CT USA
[4] Int Dermatol Res, Miami, FL USA
[5] Educ & Res Fdn, Lynchburg, VA USA
[6] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[7] Virginia Clin Res, Norfolk, VA USA
[8] Wake Forest Univ, Bowman Gray Sch Med, Dermatol Clin Studies Ctr, Winston Salem, NC USA
[9] Johnson & Johnson Consumer Prod Inc, Skillman, NJ 08558 USA
关键词
D O I
10.1016/S0190-9622(98)70267-1
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Tinea versicolor is a common superficial fungal infection caused by a lipophilic yeast. This chronically recurring opportunistic infection is especially prevalent in tropical and semitropical regions. The topical short-term application of ketoconazole 2% shampoo may provide effective and safe therapy for tinea versicolor. Objective: The purpose of this study was to evaluate the efficacy and safety of a single application (1 day) versus three daily applications (3 days) of ketoconazole 2% shampoo versus placebo shampoo in the treatment of mycologically confirmed tinea versicolor. Methods: Three hundred twelve patients were included in the primary analyses for this 31-day study. Global evaluation scores were measured on days 10 and 31 with a 5-point scale (1 = healed to 5 = worsening), and a cellophane tape test was done at baseline and days 3, 10, and 31. Efficacy was assessed by clinical response, defined as both a global evaluation score of 1 (healed) and a negative cellophane tape test on day 31. Signs and symptoms of tinea versicolor (scaling, itching, erythema, hypopigmentation, hyperpigmentation) also were evaluated at baseline, day 10, and day 31 with a 4-point scale (0 = absent to 3 = severe). Results: Both regimens of ketoconazole shampoo were significantly (P <.001) more effective than placebo for rate of clinical response, global evaluation scores, and mycologic outcomes (cellophane tape test). The clinical response rates at day 31 were 73%, 69%, and 5% for the 3-day ketoconazole, 1-day ketoconazole, and placebo groups, respectively. The difference in the efficacy of the two ketoconazole treatment regimens was not statistically significant. There were no significant differences between any of the treatment groups in the number of patients who experienced adverse events. No serious adverse events occurred and no patient withdrew from the trial prematurely because of an adverse event. Conclusion: Ketoconazole 2% shampoo, used as a single application or daily for 3 days, is safe and highly effective in the treatment of tinea versicolor.
引用
收藏
页码:944 / 950
页数:7
相关论文
共 50 条
  • [21] Randomized clinical trial: rikkunshito in the treatment of functional dyspepsiaa multicenter, double-blind, randomized, placebo-controlled study
    Suzuki, H.
    Matsuzaki, J.
    Fukushima, Y.
    Suzaki, F.
    Kasugai, K.
    Nishizawa, T.
    Naito, Y.
    Hayakawa, T.
    Kamiya, T.
    Andoh, T.
    Yoshida, H.
    Tokura, Y.
    Nagata, H.
    Kobayakawa, M.
    Mori, M.
    Kato, K.
    Hosoda, H.
    Takebayashi, T.
    Miura, S.
    Uemura, N.
    Joh, T.
    Hibi, T.
    Tack, J.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (07): : 950 - 961
  • [22] REASSESSMENT OF DEFIBRASE IN TREATMENT OF ACUTE CEREBRA LINFARCTION :A MULTICENTER ,RANDOMIZED ,DOUBLE-BLIND ,PLACEBO-CONTROLLED TRIAL
    The Cooperative Group for Reassessment of Defibrase
    [J]. Chinese Medical Sciences Journal, 2005, (03) : 151 - 158
  • [23] A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
    Hoffman, GS
    Cid, MC
    Hellman, DB
    Guillevin, L
    Stone, JH
    Schousboe, J
    Cohen, P
    Calabrese, LH
    Dickler, H
    Merkel, PA
    Fortin, P
    Flynn, JA
    Locker, GA
    Easley, KA
    Schned, E
    Hunder, GG
    Sneller, MC
    Tuggle, C
    Swanson, H
    Hernández-Rodríguez, J
    Lopez-Soto, A
    Bork, D
    Hoffman, DB
    Kalunian, K
    Klashman, D
    Wilke, WS
    Scheetz, RJ
    Mandell, BF
    Fessler, BJ
    Kosmorsky, G
    Prayson, R
    Luqmani, RA
    Nuki, G
    McRorie, E
    Sherrer, Y
    Baca, S
    Walsh, B
    Ferland, D
    Soubrier, M
    Choi, HK
    Gross, W
    Segal, AM
    Ludivico, C
    Puechal, X
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (05): : 1309 - 1318
  • [24] Boswellia serrata extract for the treatment of collagenous colitis a double-blind randomized, placebo-controlled, multicenter trial
    Madisch, A.
    Miehlke, S.
    Eichele, O.
    Mrwa, J.
    Bethke, B.
    Kuhlisch, E.
    Baestlein, E.
    Wilheims, G.
    Morgner, A.
    Wigginghaus, B.
    Stolte, M.
    [J]. PHYTOMEDICINE, 2008, 15 (6-7) : 543 - 543
  • [25] Heparan sulfate in the treatment of intermittent claudication: Results of a randomized, double-blind, placebo-controlled multicenter trial
    Messa, GL
    Gelso, E
    [J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2002, 28 (01) : 37 - 48
  • [26] Penciclovir cream for the treatment of herpes simplex labialis - A randomized, multicenter, double-blind, placebo-controlled trial
    Spruance, SL
    Rea, TL
    Thoming, C
    Tucker, R
    Saltzman, R
    Boon, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (17): : 1374 - 1379
  • [27] A European Multicenter Randomized Double-blind Placebo-controlled Monotherapy Clinical Trial of Milnacipran in Treatment of Fibromyalgia
    Branco, Jaime C.
    Zachrisson, Olof
    Perrot, Serge
    Mainguy, Yves
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (04) : 851 - 859
  • [28] A DOUBLE-BLIND TRIAL OF 1-PERCENT KETOCONAZOLE SHAMPOO VERSUS PLACEBO IN THE TREATMENT OF DANDRUFF
    GO, IH
    WIENTJENS, DPWM
    KOSTER, M
    [J]. MYCOSES, 1992, 35 (3-4) : 103 - 105
  • [29] Effects of Omeprazole on Sleep Disturbance: Randomized Multicenter Double-Blind Placebo-Controlled Trial
    Aimi, Masahito
    Komazawa, Yoshinori
    Hamamoto, Naoharu
    Yamane, Yuko
    Furuta, Koichiro
    Uchida, Yasushi
    Yano, Shozo
    Morita, Miwa
    Oguro, Hiroaki
    Miyake, Tatsuya
    Sugimoto, Toshitsugu
    Nagi, Seiichi
    Naora, Kohji
    Goubaru, Yoshiyuki
    Ishihara, Shunji
    Kinoshita, Yoshikazu
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2014, 5
  • [30] Adalimumab in Severe and Acute Sciatica A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Genevay, Stephane
    Viatte, Sebastien
    Finckh, Axel
    Zufferey, Pascal
    Balague, Federico
    Gabay, Cem
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (08): : 2339 - 2346